§ 13F · FUND PROFILE
Squadron Capital Management LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 33Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$236.0T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | RLMD | RELMADA THERAPEUTICS INC | 6.70M | $32.4T | 13.7% | NEW |
| 2 | COGT | COGENT BIOSCIENCES INC | 780K | $27.7T | 11.7% | NEW |
| 3 | MAZE | MAZE THERAPEUTICS INC | 490K | $20.3T | 8.6% | NEW |
| 4 | ABVX | ABIVAX SA | 145K | $19.6T | 8.3% | NEW |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | 700K | $11.3T | 4.8% | NEW |
| 6 | PALI | PALISADE BIO INC | 4.50M | $10.6T | 4.5% | NEW |
| 7 | EWTX | EDGEWISE THERAPEUTICS INC | 350K | $8.7T | 3.7% | NEW |
| 8 | IKT | INHIBIKASE THERAPEUTICS INC | 4.22M | $8.7T | 3.7% | NEW |
| 9 | KOD | KODIAK SCIENCES INC | 292K | $8.2T | 3.5% | NEW |
| 10 | TERN | TERNS PHARMACEUTICALS INC | 190K | $7.7T | 3.3% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SQUADRON SIGNAL
AC read
Squadron Capital Management LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed